The only tuberculosis vaccine currently approved, the Bacillus Calmette-Guérin (BCG) vaccine, protects children from the most severe forms of the disease in most cases but does not provide protection against the most common ...
Mar 24, 2015
0
22
Lung diseases in the Middle East range from the centuries-old pulmonary tuberculosis (TB) to modern manifestations caused by chemical warfare. A new paper now available in Respirology, a journal of the Asian Pacific Society ...
Jul 13, 2011
0
0
Researchers at the University of St Andrews are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.
Oct 28, 2016
0
22
Tuberculosis remains the most deadly infectious diseases in the world. In particular, the growing number of multiresistant microbes is a cause of great concern to doctors and healthcare policymakers. At least a dozen candidate ...
Mar 23, 2018
0
3
Tuberculosis independently predicts death from lung cancer in the elderly, according to a new study from researchers in Hong Kong.
May 21, 2012
0
0
"New weapon in fight against the deadliest disease! Medicine can be used to treat existing illness and prevent reoccurrence." These headlines were published 125 years ago and shook up not only the world of science and medicine, ...
Mar 23, 2016
0
8
Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed ...
Apr 9, 2012
0
0
Researchers have shown that a single nucleotide change in a gene that affects production of hepcidin—a peptide involved in inflammation, immunity, and control of iron levels—is associated with greater susceptibility to ...
Jul 21, 2017
0
0
A new study shows that young children diagnosed with pulmonary tuberculosis are at an increased risk of subsequent wheezing, poor lung function, and reduced height and weight later in their childhood.
Apr 18, 2023
0
15
(HealthDay)—For patients with uncomplicated, smear-positive pulmonary tuberculosis, moxifloxacin-containing regimens over four months are not noninferior to a control regimen, according to a study published online Sept. ...
Sep 8, 2014
0
0
